ROVI updates its strategy in a meeting with shareholders, investors and analysts
Mar, 16/11/2021 - 14:31
1 minROVI updates its strategy in a meeting with shareholders, investors and analysts
Relacionados
En cumplimiento de los deberes de información previstos en el artículo 227 de la Ley 6/2023, de 17 de marzo, de los Mercados de Valores y...
2 min
01/04/2026
Los ingresos totales se situaron en los 756,1 millones de euros, un descenso del 1% con respecto a 2024.
Los ingresos operativos se...
10 min
25/02/2026
En cumplimiento de los deberes de información previstos en el artículo 227 de la Ley 6/2023, de 17 de marzo, de los Mercados de Valores y...
1 min
18/11/2025
shutterstock_1323088832.jpg
TO THE SPANISH NATIONAL SECURITIES MARKET COMMISSION
(COMISIÓN NACIONAL DEL MERCADO DE VALORES)
Madrid, 16 November 2021
In compliance with the reporting requirements provided for in article 227 of the consolidated text of the Securities Market Act, ROVI sends and publishes the attached presentation regarding the update of the company strategy, a presentation that will be distributed today and which can be accessed through the website of the company. Likewise, ROVI will hold a virtual meeting today with analysts and investors to present said presentation.
Mr. Juan López-Belmonte Encina
Chairman and Chief Executive Officer
Laboratorios Farmacéuticos ROVI, S.A.